SRSF2 and myelodysplastic syndrome: In MDS, mutations of genes involved in the pre-mRNA splicing (SF3B1, SRSF2, U2AF1, and ZRSR2) are frequently detected and occur in more than 50% of all MDS patients [70,71,107] suggesting that the spliceosomal dysfunction plays a major role in disease pathogenesis.